BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 21589858)

  • 41. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
    Wei H; Ahn S; Barnes WG; Lefkowitz RJ
    J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.
    Ali H; Ahamed J; Hernandez-Munain C; Baron JL; Krangel MS; Patel DD
    J Immunol; 2000 Dec; 165(12):7215-23. PubMed ID: 11120854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.
    Ménard L; Ferguson SS; Zhang J; Lin FT; Lefkowitz RJ; Caron MG; Barak LS
    Mol Pharmacol; 1997 May; 51(5):800-8. PubMed ID: 9145918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1.
    Dalle S; Imamura T; Rose DW; Worrall DS; Ugi S; Hupfeld CJ; Olefsky JM
    Mol Cell Biol; 2002 Sep; 22(17):6272-85. PubMed ID: 12167719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.
    Singh M; Moniri NH
    Biochem Pharmacol; 2012 Sep; 84(5):661-9. PubMed ID: 22728070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional desensitization of the extracellular calcium-sensing receptor is regulated via distinct mechanisms: role of G protein-coupled receptor kinases, protein kinase C and beta-arrestins.
    Lorenz S; Frenzel R; Paschke R; Breitwieser GE; Miedlich SU
    Endocrinology; 2007 May; 148(5):2398-404. PubMed ID: 17255208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
    Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
    Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates
    Senatorov IS; Cheshmehkani A; Burns RN; Singh K; Moniri NH
    Mol Pharmacol; 2020 May; 97(5):304-313. PubMed ID: 32132133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arrestin specificity for G protein-coupled receptors in human airway smooth muscle.
    Penn RB; Pascual RM; Kim YM; Mundell SJ; Krymskaya VP; Panettieri RA; Benovic JL
    J Biol Chem; 2001 Aug; 276(35):32648-56. PubMed ID: 11418617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
    Daniele S; Trincavelli ML; Fumagalli M; Zappelli E; Lecca D; Bonfanti E; Campiglia P; Abbracchio MP; Martini C
    Cell Signal; 2014 Jun; 26(6):1310-25. PubMed ID: 24613411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking.
    Kohout TA; Lin FS; Perry SJ; Conner DA; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1601-6. PubMed ID: 11171997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.
    Rajagopal S; Kim J; Ahn S; Craig S; Lam CM; Gerard NP; Gerard C; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):628-32. PubMed ID: 20018651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
    Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ERK5 activation by Gq-coupled muscarinic receptors is independent of receptor internalization and β-arrestin recruitment.
    Sánchez-Fernández G; Cabezudo S; García-Hoz C; Tobin AB; Mayor F; Ribas C
    PLoS One; 2013; 8(12):e84174. PubMed ID: 24358341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization.
    Qiu Y; Loh HH; Law PY
    J Biol Chem; 2007 Aug; 282(31):22315-23. PubMed ID: 17565992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism.
    Rodriguez P; Laskowski LJ; Pallais JP; Bock HA; Cavalco NG; Anderson EI; Calkins MM; Razzoli M; Sham YY; McCorvy JD; Bartolomucci A
    J Biol Chem; 2024 Jan; 300(1):105549. PubMed ID: 38072064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.
    Sun J; Lin X
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17085-90. PubMed ID: 18952848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Divergent β-arrestin-dependent signaling events are dependent upon sequences within G-protein-coupled receptor C termini.
    Pal K; Mathur M; Kumar P; DeFea K
    J Biol Chem; 2013 Feb; 288(5):3265-74. PubMed ID: 23235155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis.
    Hunton DL; Barnes WG; Kim J; Ren XR; Violin JD; Reiter E; Milligan G; Patel DD; Lefkowitz RJ
    Mol Pharmacol; 2005 Apr; 67(4):1229-36. PubMed ID: 15635042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.